1. The selected strain of Bifidobacterium NCIMB 41676.2. The Bifidobacterium strain of claim 1 in the form of viable cells. The Bifidobacterium strain according to claim 1 in the form of non-viable cells. The Bifidobacterium strain according to any one of claims 1 to 3, isolated from a sample of a tissue of a colon of a healthy person obtained by biopsy. The Bifidobacterium strain according to claim 1, having a significant immunomodulatory effect when it is ingested by humans. The Bifidobacterium strain according to claim 1, acting antagonizing and displacing pro-inflammatory microorganisms from the gastrointestinal tract. The Bifidobacterium strain according to claim 1, used to prepare anti-inflammatory biotherapeutic agents used to prevent and / or treat unwanted inflammatory processes. The strain Bifidobacterium according to claim 7, used to prepare a number of biotherapeutic agents used to correct the level of IL-10.9. A composition containing a strain of Bifidobacterium according to claim 1.10. The composition according to claim 9, additionally containing probiotic material. The composition of claim 9 or 10, further comprising prebiotic material. The composition of claim 9, further comprising a carrier for oral administration. The composition of claim 12, wherein the oral carrier is a pharmaceutically acceptable carrier, such as a capsule, tablet or powder. The composition of claim 12, wherein the oral carrier is a food product, such as fermented milk, yogurt, frozen yogurt, milk powder, concentrated milk, cheese pastes, dressings or drinks. The composition of claim 9, further comprising a protein and / or peptide, in particular proteins or peptides rich in glutamine / glutamate, lipid, carbohydrate, vitamin, mineral and / or trace element. The composition according to claim 9, in the cat1. Выделенный штамм Bifidobacterium NCIMB 41676.2. Штамм Bifidobacterium по п.1 в форме жизнеспособных клеток.3. Штамм Bifidobacterium по п.1 в форме нежизнеспособных клеток.4.
